Warnex Inc.
TSX : WNX

Warnex Inc.

September 19, 2011 07:01 ET

Warnex Launches PRO-DNA® Lead, a New Forensic DNA Testing Service

Warnex collaborates with Sorenson Forensics

LAVAL, QUEBEC--(Marketwire - Sept. 19, 2011) - Warnex Inc. (TSX:WNX) announced today that its subsidiary, Warnex PRO-DNA Services, located in Thunder Bay, Ontario, has launched PRO-DNA® Lead, a new investigative DNA testing service. Warnex has signed an exclusive agreement with Sorenson Forensics, a forensic DNA testing company based in Salt Lake City, Utah, to offer this new service in Canada.

"We are pleased to collaborate with Sorenson Forensics to offer this new service to investigators and law enforcement agencies across Canada," said Mark Busgang, President and CEO of Warnex. "PRO-DNA® Lead can provide valuable information to help further investigations, particularly in cases that have had no hits in CODIS and have reached a dead end."

"We are excited to begin a collaboration with Warnex, the premier forensic DNA testing firm in Canada," said Tim Kupferschmid, Executive Director of Sorenson Forensics. "In addition to helping solve cold cases, PRO-DNA® Lead can also assist in the identification of unknown victims."

Warnex's PRO-DNA® Lead service can provide investigative leads by determining the ancestral background of a suspect or victim based on crime scene samples. PRO-DNA® Lead uses DNA markers called Ancestry Informative Markers (AIM) to ascertain an individual's genetic ancestry. AIMs are composed of single base pair polymorphisms (SNP) in DNA sequences that vary between human populations.

PRO-DNA® Lead analyzes the affinity of an unknown human DNA sample to 5 reference populations (West Europe, East Asia, West Africa, Indigenous America and India Subcontinent) to determine the individual's genetic ancestry and provide a clue as to the individual's physical appearance.

For more information on this service and Warnex's other forensic services, visit www.prodna.ca.

About Sorenson Forensics

Sorenson Forensics (www.sorensonforensics.com) is a leading provider of advanced forensic DNA services and offers industry-best casework assistance to federal, state and local crime laboratories, assists officers of the court in individual criminal cases, and offers comprehensive forensic DNA services to private industry clients. Sorenson Forensics provides services, such as STR and Y-STR analysis; ancestry testing; comprehensive biology screening; full serology testing, including blood, semen and other body fluid identification; DNA case consultation; expert testimony, validation services and laboratory optimization services. The Sorenson Forensics team consists of individuals internationally recognized for their extensive public and private crime lab experience and for their rigor in the exacting requirements of forensics casework. Sorenson Forensics has established an extraordinary record for helping to crack difficult-to-resolve cases, including previously unsolved "cold cases."

About Warnex

Warnex (www.warnex.ca) is a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical and healthcare sectors. Warnex Analytical Services provides pharmaceutical and biotechnology companies with a variety of quality control services, including chemistry, chromatography, microbiology, method development and validation, and stability studies. Warnex Bioanalytical Services specializes in bioequivalence and bioavailability studies for clinical trials. Warnex Medical Laboratories provides specialized testing for the healthcare industry as well as pharmaceutical and central laboratory services. Warnex PRO-DNA Services offers DNA identification tests for paternity, maternity and other family relationships, as well as for immigration and forensic testing purposes. Warnex has three facilities located in Laval and Blainville, Quebec, and Thunder Bay, Ontario.

PRO-DNA is a registered trademark of Warnex Inc., Laval, Quebec.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties, relating to financial resources, liquidity risk, key customers and business partners, credit risk, foreign currency risk, government regulations, laboratory facilities, volatility of share price, employees, suppliers, and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Warnex's most recent Management's Discussion and Analysis, which can be found at www.sedar.com. Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.

Contact Information